Amorphigenin
Amorphigenin is a trothotenone compound. Amorphigenin inhibits osteoclast differentiation by suppressing the expression of c-Fos and NFATc1 in activated T cells. Amorphigenin degrades melanosome proteins by activating the AMPK-dependent autophagy pathway, but not in dependence of the mTOR pathway. Amorphigenin significantly protects bone mass and reduces bone erosion in a mouse model of inflammatory bone loss. Amorphigenin can be used to study inflammatory bone diseases, postmenopausal osteoporosis, and skin pigmentation disorders[1][2].
Product Specifications
CAS Number
4208-09-7
UNSPSC
12352005
Target
AMPK; AP-1; Autophagy; Nuclear Factor of activated T Cells (NFAT)
Related Pathways
Autophagy; Epigenetics; Immunology/Inflammation; PI3K/Akt/mTOR
Field of Research
Endocrinology; Metabolic Disease; Inflammation/Immunology
Smiles
O=C1[C@@]2([C@]([H])(OC3=C1C=CC4=C3C[C@@H](O4)C(CO)=C)COC5=C2C=C(C(OC)=C5)OC)[H]
Molecular Formula
C23H22O7
Molecular Weight
410.42
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
C-Fos
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
JAZF1 (TIP27, ZNF802, Juxtaposed with Another Zinc Finger Protein 1, TAK1-interacting Protein 27, Zinc Finger Protein 802, DKFZp761K2222) (MaxLight 650)
FITC-Linked Monoclonal Antibody to Hemojuvelin (HJV)